Journal of Labelled Compounds and Radiopharmaceuticals · 2001 · 32 citations · 11 references
Life SciencesNeurosciencePharmacologyMolecular NeuroscienceNeurochemistryNeuropharmacologyNeurotransmissionSerotonergic PharmacologySerotonergic SignalingPrecursor CompoundsRadiochemical Purity AssessmentRadiochemical Purity TestingRadiochemical SynthesisRadioligand Binding AssaysRadioligand ImagingSerotonergic NeurotransmissionSerotonin Transporter Pharmacology
Abstract The serotoninergic system is involved in a variety of neurological and psychiatric disorders. Exploration of the serotonin transporters (5‐HTT) in living human brain by PET would be of great value for better understanding, diagnosis and therapeutic follow up of these diseases. In order to obtain a selective radioligand to explore the 5‐HTT by PET we report the synthesis of [ 11 C]N,N‐dimethyl‐2‐(2‐amino‐4‐iodophenylthio)‐benzylamine ([ 11 C]ADAM). The precursor for labelling N‐demethyl ADAM, was obtained in five steps using 2,5‐dibromonitrobenzene and 2‐thio‐N‐methylbenzamide as starting material. [ 11 C]ADAM was synthesised by N‐alkylation of the precursor using [ 11 C]methyl iodide in DMF. The incorporation yield of [ 11 C]methyl iodide was in the range of 50 to 70%. Finally [ 11 C]ADAM was obtained in 30 minutes synthesis time including HPLC and with a radiochemical purity better than 99%. Copyright © 2001 John Wiley & Sons, Ltd.
11
[11C](+)McN5652 as a radiotracer for imaging serotonin uptake sites with pet
Makiko Suehiro, Ursula Scheffel, Hayden T. Ravert et al. · Life Sciences · 1993 · 105 citations
Jukka O. Hiltunen, Kari K. �kerman, Jyrki T. Kuikka et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1997 · 73 citations
Medicine, Neuroscience, Pharmacology +17